Description: Chongqing Lummy Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products in China. The company provides tumor, antibacterial, antiviral, and antifungal, as well as liver disease auxiliary, endocrinology system, and Chinese patent drugs; digestive system, immune system, blood system, cardiovascular system, and nervous system drugs; electrolyte and acid-base products; balance and nutritional products; and base large infusion products, American ginseng systems, and active pharmaceutical ingredients. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is based in Chongqing, China.
Home Page: www.cqlummy.com
Yu Ma Road No. 99
Chongqing,
401336
China
Phone:
Officers
Name | Title |
---|---|
Mr. Xue Feng Leng | Deputy GM & Vice Chairman |
Mr. Dan Cui | Deputy GM, Sec. & Gen. Counsel |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 2.1316 |
Price-to-Sales TTM: | 4.6363 |
IPO Date: | 2009-10-30 |
Fiscal Year End: | December |
Full Time Employees: | 935 |